New York State Common Retirement Fund Tarsus Pharmaceuticals, Inc. Transaction History
New York State Common Retirement Fund
- $74.9 Billion
- Q3 2025
A detailed history of New York State Common Retirement Fund transactions in Tarsus Pharmaceuticals, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 48,607 shares of TARS stock, worth $3.51 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
48,607
Previous 43,004
13.03%
Holding current value
$3.51 Million
Previous $1.74 Million
65.79%
% of portfolio
0.0%
Previous 0.0%
Shares
25 transactions
Others Institutions Holding TARS
# of Institutions
231Shares Held
45MCall Options Held
51.6KPut Options Held
15.8K-
Black Rock Inc. New York, NY3.27MShares$236 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY3.18MShares$229 Million2.52% of portfolio
-
Deep Track Capital, LP Greenwich, CT3MShares$217 Million5.63% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY2.67MShares$192 Million5.1% of portfolio
-
Jennison Associates LLC2.6MShares$188 Million0.09% of portfolio
About Tarsus Pharmaceuticals, Inc.
- Ticker TARS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,658,500
- Market Cap $1.92B
- Description
- Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as...